Gluten is a group of proteins found in wheat, barley, and rye that can trigger a specific inflammatory and autoimmune response in genetically predisposed individuals, leading to damage of the small intestinal lining. The process combines barrier dysfunction, immune recognition, and chronic inflammation, producing the characteristic malabsorption and systemic effects seen in celiac disease.
Mechanism at the intestinal barrier
The peptide fraction of gluten known as gliadin interacts with the intestinal epithelium and can stimulate release of zonulin, a regulator of tight junctions between epithelial cells. Research by Alessio Fasano, Massachusetts General Hospital shows that zonulin-mediated opening of tight junctions increases intestinal permeability, allowing larger gliadin fragments to cross the epithelial barrier and contact immune cells in the lamina propria. This increased permeability is a critical first step: without it, large gluten peptides are far less likely to access the immune system and trigger downstream events. Not everyone exposed to gliadin develops this zonulin response, and zonulin levels vary with infection, microbiome composition, and other environmental factors.
Immune activation and tissue damage
Once gliadin peptides cross the epithelium, they are modified by tissue transglutaminase, enhancing their binding to specific HLA molecules on antigen-presenting cells. Individuals who carry HLA-DQ2 or HLA-DQ8 are at markedly increased risk because these molecules present deamidated gliadin to CD4 positive T cells, initiating an autoimmune response. Peter H. R. Green, Columbia University Irving Medical Center explains that activated T cells and autoantibodies against tissue transglutaminase amplify local inflammation, leading to villous atrophy and crypt hyperplasia, the structural changes that reduce the absorptive surface of the small intestine. Genetic susceptibility is necessary but not always sufficient; many carriers of HLA-DQ2 or HLA-DQ8 never develop full-blown disease.
Damage to the villi impairs absorption of iron, calcium, fat-soluble vitamins, folate, and other nutrients, producing anemia, osteoporosis, failure to thrive in children, and weight loss. Chronic untreated inflammation also raises long-term risks such as enteropathy-associated T-cell lymphoma and other complications documented in clinical reviews and guidance from the National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health.
Cultural and territorial context shapes both exposure and outcomes. In regions where wheat is a dietary staple, symptomatic disease may present early in life and influence growth and social practices around food. Access to safe, certified gluten-free foods varies widely; in many low-resource settings, avoiding gluten is difficult and diagnosis may be delayed. Environmental factors like early gastrointestinal infections, the developing microbiome, and breastfeeding practices can modify risk and presentation, a nuance highlighted across epidemiologic studies.
Removal of dietary gluten usually halts the immune cascade and permits mucosal recovery, though the pace of healing differs by age and extent of damage. Accurate diagnosis and follow-up care are essential to prevent long-term consequences and to address nutritional and social impacts of the disease.